Julie Stover

Researcher

UAMS

Unknown Researcher

4 h-index 9 pubs 86 cited

Research Areas

OverviewAI-generated summary

Julie Stover's research has focused on the study of behavioral and psychological topics, with a recent publication in 2004. Her work has explored various aspects of human behavior and mental processes, though her active research period concluded over a decade ago. Her contributions lie in the foundational understanding of psychological principles.

Metrics

h-index: 4
Publications: 9
Citations: 86

Selected Publications

Osteoblastic Activation and Response to Velcade® in Patients with Relapsed/Refractory Multiple Myeloma (MM). (2004)

Blood DOI OpenAlex
Addition of Bortezomib (Velcade™) to High Dose Melphalan (Vel-Mel) as an Effective Conditioning Regimen with Autologous Stem Cell Support in Multiple Myeloma (MM). (2004)

Blood 22 citations DOI OpenAlex
Hematopoietic Progenitor Cell (HPC) Mobilization after Initial Therapy of Multiple Myeloma Including Velcade: Ability to Collect HPC as a Function of Velcade Dosing. (2004)

Blood 4 citations DOI OpenAlex
Bortezomib (Velcade™) + Adriamycin™ + Thalidomide + Dexamethasone (VATD) as an Effective Regimen in Patients with Refractory or Relapsed Multiple Myeloma (MM). (2004)

Blood 28 citations DOI OpenAlex
Total Therapy 2 (TT 2) for Newly Diagnosed Patients with Multiple Myeloma (MM): Examination of Dose Effect of Thalidomide (T) among Those Randomized to T. (2004)

Blood DOI OpenAlex
Protective Effect of VELCADE® on Thalidomide-Associated Deep Vein Thrombosis (DVT). (2004)

Blood 12 citations DOI OpenAlex
Collection of Peripheral Blood Stem Cells in 668 Patients with Multiple Myeloma Treated on Total Therapy II (UARK 98-026). (2004)

Blood 1 citation DOI OpenAlex
Lack of Prognostic Implications of Induction Response to Total Therapy 2 (TT-2) in Newly Diagnosed Patients with Multiple Myeloma (MM) for Post-Transplant Even-Free Survival (EFS) and Overall Survival (OS). (2004)

Blood 2 citations DOI OpenAlex